A previous study reported that GLI1 and GLI2 mRNA levels, indicators of active HH signaling, were significantly higher in cancer cells isolated from persistent/chemoresistant ovarian tumors than those isolated from matched primary tumors [28]. The gene discussed is GLI2; the disease is cancer.